title: Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families.
abstract: Non-diabetic first degree relatives of non-insulin-dependent diabetic (NIDDM) families are at increased risk of developing diabetes mellitus, and have been studied to identify early metabolic abnormalities. Hormone concentrations measured by specific enzyme immunoassays were assessed in non-diabetic relatives of North European extraction, and control subjects with no family history of diabetes were matched for age, sex and ethnicity. A 75-g oral glucose tolerance test was conducted and those with newly diagnosed NIDDM were excluded. Basal insulin resistance was determined by homeostasis model assessment (HOMA), and hepatic insulin clearance by C-peptide:insulin molar ratio. Relatives (n = 150) were heavier (BMI: p < 0.0001) than the control subjects (n = 152), and had an increased prevalence of impaired glucose tolerance (15 vs 3%, p < 0.01). The relatives had increased fasting proinsulin levels and decreased C-peptide levels following the glucose load, while insulin levels were increased at all time points. To examine whether the differences in hormone levels were secondary to the differences in glucose tolerance and adiposity, we studied 100 normal glucose tolerant relatives and control subjects pair-matched for age, sex, waist-hip ratio and BMI. The differences in proinsulin levels were no longer apparent. However, the relatives remained more insulin resistant, and had decreased C-peptide levels and C-peptide:insulin ratios at all time points. In conclusion, we have identified several metabolic abnormalities in the normal glucose tolerant relatives, and propose that the decreased hepatic insulin clearance helps to maintain normoglycaemia in the face of combined insulin resistance and decreased insulin secretion.
authors.affiliation: Human Diabetes and Metabolism Research Centre and Department of Medicine, University of Newcastle upon Tyne, UK.
authors.forename: D B
authors.initials: DB
authors.lastname: Humphriss
authors.forename: M W
authors.initials: MW
authors.lastname: Stewart
authors.forename: T S
authors.initials: TS
authors.lastname: Berrish
authors.forename: L A
authors.initials: LA
authors.lastname: Barriocanal
authors.forename: L R
authors.initials: LR
authors.lastname: Trajano
authors.forename: L A
authors.initials: LA
authors.lastname: Ashworth
authors.forename: M D
authors.initials: MD
authors.lastname: Brown
authors.forename: M
authors.initials: M
authors.lastname: Miller
authors.forename: P J
authors.initials: PJ
authors.lastname: Avery
authors.forename: K G
authors.initials: KG
authors.lastname: Alberti
authors.forename: M
authors.initials: M
authors.lastname: Walker
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics* / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D011384:Proinsulin / Q000097:blood; D012016:Reference Values
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011384:Proinsulin